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Molecular mechanisms that lead to congenital anomalies of kidneys and the lower urinary tract (CAKUT) are
poorly understood. To elucidate the molecular basis for signaling specificity of GDNF-mediated RET signaling
in kidney development, we characterized mice that exclusively express either the human RET9 or RET51
isoform, or express these isoforms with individual mutations in docking tyrosines for PTB and
SH2-domain-containing adaptors Src (Y981), PLC (Y1015), and Shc (Y1062). Our results provide evidence for
differential and isoform-specific roles of these docking sites in murine kidney development. Homozygous
RetRET9 and RetRET51 mice were viable and show normally developed kidneys, indicating redundant roles of
human RET isoforms in murine kidney development. In the context of the RET51 isoform, only mutation of
the docking Tyr 1015 (Y1015F) resulted in severe renal anomalies. These included bilateral megaureters and
multicystic kidneys that were caused by supernumerary ureteric buds that fail to separate from the wolffian
duct as well as decreased branching morphogenesis. Similar kidney and ureter defects were observed in
RET9(Y1015F) mice that contain the Y1015F mutation in the RET9 isoform. Interestingly, loss of
RET9(Y1062)-mediated AKT/MAPK activation resulted in renal agenesis or kidney rudiments, whereas
mutation of this residue in RET51 had no obvious effect on AKT/MAPK activity and renal development.
These results reveal novel roles of key RET-dependent signaling pathways in embryonic kidney development
and provide murine models and new insights into the molecular basis for CAKUT.
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Several biological processes such as organogenesis and
diseases like cancer depend on receptor tyrosine kinase
(RTK) signaling. Upon activation by ligands/coreceptors,
RTKs typically interact with intracellular adaptor pro-
teins via docking phosphotyrosines and activate several
signaling cascades such as PKC, AKT, and MAPK
(Madhani 2001). While physiological roles of several
RTKs have been elucidated by gene knockout studies,
little is known about how specific intracellular signaling
pathways meditate their pleiotropic effects in vivo.
The RET RTK is critical for the development of the
lineages of the peripheral nervous system, the kidneys,
and the testes (Sariola and Saarma 2003; Jain et al. 2004).
Congenital renal abnormalities are one of the most com-
mon developmental defects in children. Aberrant RET
signaling in the developing murine kidney results in con-
genital anomalies of the kidneys and the lower urinary
tract (CAKUT) (Pope et al. 1999). These include renal
agenesis, hypoplasia, hypodysplasia, multicystic kid-
neys, and defective ureteral maturation (Schuchardt et
al. 1994; Srinivas et al. 1999; de Graaff et al. 2001; Eno-
moto et al. 2001; Batourina et al. 2002; Jain et al. 2004;
Jijiwa et al. 2004). Recent evidence also suggests that
genitourinary (GU) defects due to deficiencies in other
signaling proteins may also be mediated via RET (Gries-
hammer et al. 2004; Basson et al. 2005), but the molecu-
lar basis for how deficits in RET signaling lead to such a
wide array of GU defects is unknown.
RET forms a signaling complex with one of the GDNF
family ligands (GFLs-GDNF, Neurtirin, Artemin, or Per-
sephin) and a coreceptor GFR (GFR1–4) (Baloh et al.
2000). In renal development, GDNF-mediated RET sig-
naling is physiologically important as Gdnf-, Gfr1-, or
Ret-null mice die perinatally due to bilateral renal agen-
esis (Schuchardt et al. 1994, 1996; Moore et al. 1996;
Pichel et al. 1996; Sanchez et al. 1996; Cacalano et al.
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1998; Enomoto et al. 1998, 2001). Kidney development
depends on reciprocal inductive interactions between
the GDNF-producing mesenchyme and the ureteric bud
(UB) epithelium, which expresses RET/GFR1 (Lechner
and Dressler 1997; Yu et al. 2004). At embryonic day 11.5
(E11.5), GDNF initiates UB outgrowth from the wolffian
duct, which, in turn, invades the metanephric mesen-
chyme, causing its differentiation into epithelium and
the formation of nephrons. In turn, the mesenchyme se-
cretes factors that promote branching morphogenesis of
the UB that eventually differentiates into the collecting
duct system. Disruption of any of these events results in
CAKUT.
RET activation results in phosphorylation of key dock-
ing tyrosines that bind to several adaptor proteins such
as Src (at Y981); PLC (at Y1015); Shc; FRS2; IRS1 and
IRS2; Enigma; Doks 4, 5, and 6 (at Y1062); and Grb2 (at
Y1096). These interactions activate downstream signal
transduction pathways such as Raf/Ras (Src), PKC
(PLC), PI3K/AKT, and MAPK (Shc and Grb2) (Air-
aksinen and Saarma 2002). These cascades mediate RET-
stimulated cell proliferation, migration, differentiation,
and survival. RET signaling via specific intracellular
signaling cascades may be regulated by alternative splic-
ing, as there are two major splice isoforms, RET9 and
RET51. RET9 (1072 amino acids long) and RET51 (1114
amino acids long) diverge after residue 1063, and thus
are identical except for the C-terminal cytoplasmic do-
main (Takahashi 2001). The physiologic roles of these
two isoforms and the signaling pathways emanating
from specific phosphorylated tyrosine docking sites
have been studied in vitro, but information in vivo is
limited. The relative importance of the RET isoforms
and particular docking sites has differed depending on
the system investigated (Liu et al. 1996; Rossel et al.
1997; Borrello et al. 2002; Tsui-Pierchala et al. 2002). In
mice that exclusively express chimeric mouse–human
Ret9 or Ret51, it was found that Ret9 alone is suffi-
cient for kidney development, whereas Ret51 did
not promote normal renal formation (de Graaff et al.
2001).
To determine if specific RET phosphotyrosine docking
sites guide distinct biological processes, and to study the
molecular basis of RET-mediated pleiotropic effects in
kidney development and CAKUT, we characterized
mice that harbor individual RET(Tyr–Phe) mutations in
the human RET9 and RET51 isoforms. In contrast to a
prior report, we find that both homozygous RetRET9 and
RetRET51 kidneys develop normally (de Graaff et al.
2001). However, individual phosphotyrosine docking
sites of these isoforms have specific roles in kidney de-
velopment. The disruption of Y1015-mediated PLC ac-
tivation, in either the RET9 or RET51 isoform, results in
supernumerary UBs and hypodysplastic kidneys with de-
creased branching morphogenesis and increased apopto-
sis, leading to changes consistent with obstructive ne-
phropathy and death by 1 mo of age. Interestingly, the
Y1062F mutation led to severe renal dysgenesis, similar
to that seen in Ret-null mice, in RET9, but not in RET51
mice. These results indicate that the docking tyrosines
of the two RET isoforms have different signaling proper-
ties in vivo. These genetically defined RET mutant mice
provide useful models to study the congenital defects of
the GU system and will help define the molecular
mechanisms underlying these defects.
Results
Generation of mice expressing RET signaling mutants
To study the roles of RET isoforms and their key docking
tyrosines (Y981, Y1015, Y1062) in kidney development,
we targeted wild-type human RET9 or RET51 cDNA, or
the indicated mutant cDNAs of each of these isoforms
into the endogenous Ret locus using homologous recom-
bination (knockout–knockin approach) (Fig. 1A) as pre-
viously described (Enomoto et al. 2001; Jain et al. 2004).
This strategy ensured that we could properly compare
phenotypes between mice harboring RET mutations
with those expressing the wild-type knocked-in RET iso-
forms. A total of 10 different genetically engineered RET
mutant mice were created (Fig. 1B). We used RT–PCR
analysis of brain RNA to detect mRNAs corresponding
to endogenous mouse Ret, the isoform-specific RET9 or
RET51, and total RET to confirm the successful genera-
tion of each respective RET mutant, and to show that
homozygous mutant mice had no endogenous mouse
Ret expression (Fig. 1C). Immunohistochemical analysis
confirmed that RET protein was detected in the nephro-
genic zone of the kidneys or in other Ret-dependent tar-
get tissues in all RET mutant mice (Fig. 1D; data not
shown). All of the homozygous RET mutant mice were
born at the expected Mendelian frequencies as antici-
pated since RET is not required for survival during em-
bryogenesis (Schuchardt et al. 1994; Enomoto et al.
2001). For all of the studies reported here, RET mutant
mice from a mixed genetic background (129/SvJ:C57BL/
6: F2–F5) were used.
RET isoforms have redundant roles in kidney formation
We generated RetRET9/RET9 and RetRET51/RET51 mice to
examine the biological differences between the human
RET isoforms and to use these monoisomorphic mice
(exclusively express one RET isoform) as controls for
mice expressing each of the respective RET monoiso-
morphic mutants. In contrast to previous reports, we
found that both RetRET9/RET9 and RetRET51/RET51 mice
were viable. We performed biochemical analysis using
superior cervical ganglion (SCG) neurons from each of
these mice and found that the expression of RET in these
monoisomorphic mice was comparable (∼60%–80% of
wild-type Ret levels), and that GDNF-dependent activa-
tion of MAPK and AKT was intact in both RetRET9/RET9
and RetRET51/RET51 mice (Fig. 2A). Further analysis of
these mice revealed normally located gonads, no overt
defects in the enteric nervous system, and essentially
normally developed kidneys (n > 50 mice for each geno-
type) (Fig. 2B; data not shown). The only urinary system
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Figure 1. Generation of mice expressing various RET signaling mutants. (A) Mutant or wild-type human RET cDNAs were intro-
duced into exon 1 (black box) of the mouse Ret locus (black triangles, loxP sites). The restriction sites ([K] KpnI; [N] NcoI) and length
of the expected fragments in Southern blots are indicated. (B) Schematic of the different wild-type RET9, RET51, and their respective
mutant knocked-in alleles. The different domains and sizes of the RET9 and RET51 alleles are indicated. The red and blue colors
represent the area of divergence between the two RET isoforms. Also indicated are the key docking tyrosine (Y) residues. Homozygous
mice were generated that harbor Tyr → Phe (Y → F) for each of the indicated tyrosines except Y1096. RET51(Cdel) is an allele in which
residues 1063–1072 of RET9 were replaced with residues 1063–1072 of RET51 (results in receptor that is essentially similar to RET51
with deletion of residues 1073–1114, including Y1096). RET9(51C) is an allele in which residues 1063–1072 of RET51 were replaced
with residues 1063–1072 of RET9 (results in a receptor that is essentially similar to RET9 with the C terminus of RET51 including
Y1096). (C, top) Schematic depicting the position of amplicons representing various mRNAs (indicated by numbers) of RET isoforms.
(Bottom) RT–PCR using total brain RNA depicts the successful generation of each mutant homozygous monoisomorphic RET mouse.
Labeling on the left indicates the RET allele being detected: (total RET) detects mouse and/or human RET; (mouse Ret) detects
endogenous mouse Ret; (total RET51) detects mouse and/or human RET51 isoform; (total RET9) detects mouse and/or human RET9
isoform. Labeling on the top indicates the genotype at the Ret locus: (+) endogenous mouse allele; (−) null allele. (D) RET immuno-
histochemistry on P0 kidneys depicts RET expression in the nephrogenic zone (arrowheads) of the indicated homozygous mutant
animals. The abnormal disorganized renal architecture in mice expressing RET51(Y1015F), RET9(Y1015F), and RET9(Y1062F) is due
to renal abnormalities; see later (arrows, kidney tubules). Bar, 25 µm.
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defect in these mice that we have not observed in wild-
type mice was a low penetrance unilateral proximal
ureter dilatation/hydronephrosis in homozygous RET51
(1/50) and RET9 (3/50) mice. The RetRET9/RET9 and
RetRET51/RET51 mice we generated live past 1 yr of age.
It was previously postulated that alternative physi-
ological roles of these two RET isoforms could be
due to differences in their C termini (Liu et al. 1996;
Rossel et al. 1997; de Graaff et al. 2001). To examine this
hypothesis further, we generated two additional RET
mutant mice. In these mutants the nine residues after
RET1063 were swapped between RET9 and RET51
cDNAs [RET9(51C) and RET51(Cdel)] to create chimeric
RET isoforms (Fig. 1B). Surprisingly, we found that
RetRET9(51C)/RET9(51C) and RetRET51(Cdel)/RET51(Cdel) mice
were also viable and had normally developed kidneys
(Fig. 2B). From these observations, we conclude that
wild-type human RET9 and RET51 isoforms have redun-
dant roles and they can execute normal kidney develop-
ment in the absence of mouse Ret. Furthermore, the C
terminus of RET51 encompassing the extra docking ty-
rosine Y1096 for Grb2 adaptor (not present in RET9) is
dispensable in vivo.
RET51(Y1015) docking tyrosine is essential for proper
formation of kidneys, ureters, and gonads
Because the RetRET51/RET51 mice are viable with essen-
tially normal kidneys, we therefore investigated if the
docking tyrosines Y981, Y1015, and Y1062 are important
for kidney development in homozygous RetRET51(Y981F),
RetRET51(Y1015F), and RetRET51(Y1062F) mice. We observed
that all RetRET51(Y1015F)/RET51(Y1015F) mice died by 5 wk
of age. The inability of RetRET51(Y1015F)/RET51(Y1015F)
mice to survive to adulthood is likely due to severe bi-
lateral GU defects (Fig. 3). Postnatal analyses of kidneys
of all RetRET51(Y1015F)/RET51(Y1015F) mice (100% pen-
etrance, n > 10) show severe dilatation of both ureters
(megaureters), hydronephrosis, obliterated renal paren-
chyma with multiple cysts, and histopathological
changes consistent with obstructive nephropathy (Fig. 3A).
To determine if these defects occurred postnatally or were
congenital, we examined RetRET51(Y1015F)/RET51(Y1015F)
kidneys at birth (P0, n > 15). These kidneys exhibit a
subset of abnormalities present in human CAKUT (Pope
et al. 1999), including bilateral hypodysplasia, multiple
cysts, and bilateral megaureters with distal stenosis (Fig.
3B). Interestingly, both gonads (ovaries and testes) failed
to descend to their normal locations due to the inability
of the vas deferens/wolffian duct to separate from the
ureters (Figs. 3B, 4B; S. Jain, unpubl.). Consistent with
hypoplasia, there was a severe reduction in the number
of glomeruli in RetRET51(Y1015F)/RET51(Y1015F) kidneys. In
comparison, P0 kidneys of RetRET51(Y981F)/RET51(Y981F)
(n > 7) and RetRET51(Y1062F)/RET51(Y1062F) (n > 30) mice
were grossly or histologically normal as evidenced by
presence of an outer nephrogenic zone, and organization
into a defined cortex, medulla, and pelvis (Fig. 3C). Low
penetrance unilateral ureteral dilatation was seen in ho-
mozygous RET51(Y1062F) mice (1/60). These studies es-
Figure 2. Mice expressing either RET51 or RET9 show normal renal development and activation of AKT/MAPK pathways. (A)
Immunoblots of extracts from primary SCG neurons (cultured for 8 d) show similar GDNF-dependent phosphorylation of downstream
signaling effectors in homozygous RET51, RET9, and wild-type mice (WT). The antibodies used were Ret (total RET), P-Akt (phospho
Akt), and P-ERK (phospho ERK). The blot was reprobed with tubulin antibody to ensure equal loading. (B) H&E-stained kidney sections
of homozygous mice for the indicated knocked-in alleles at P0 and 2 mo (2m) of age show normal kidney histology. Bar: P0, 200 µm;
2m, 50 µm.
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tablish that in the context of the human RET51 isoform,
the docking tyrosine Y1015 is critical for proper devel-
opment of both ureters, kidneys, and gonads, whereas
RET51(Y981), RET51(Y1062), and RET51(Y1096) are
largely dispensable.
Supernumerary UBs and decreased branching
morphogenesis in the absence
of RET51(Y1015) signaling
Defects in the development of the UB have been pro-
posed to cause CAKUT (Pope et al. 1999). In mouse kid-
ney development, UB outgrowth occurs by E11.5, and by
E12.5 it has typically invaded the metanephric mesen-
chyme and undergone initial branching (Vize et al. 2003).
By E15.5, the developing kidney is organized into an
outer cortex and an inner medulla, the mesenchymal to
epithelial transition has been initiated to produce vari-
ous components of the nephron, and the ureters have
separated from the wolffian duct and formed connec-
tions to the bladder. To determine the etiology of
CAKUT-like defects in RetRET51(Y1015F)/RET51(Y1015F) kid-
neys, we compared the development of these kidneys
with that of wild-type (WT) and homozygous RET51 and
RET51(Y1062F) kidneys at E12.5. Histological analysis
at E12.5 revealed that the UB successfully reached the
metanephric mesenchyme and underwent initial
branching as demonstrated by the presence of UB deriva-
tives (Fig. 4A). Note also the presence of ectopic foci of
the developing kidney in RetRET51(Y1015F)/RET51(Y1015F)
mice, suggesting that these mice have early UB develop-
ment abnormalities. By E15.5, the abnormalities in
RetRET51(Y1015F)/RET51(Y1015F) kidneys were readily evi-
dent. Histological analysis clearly highlights the ectopic
kidney, suggesting the possibility of multiple UB induc-
tions. Furthermore, the RetRET51(Y1015F)/RET51(Y1015F)
kidneys fail to establish a normal architecture including
an outer cortex and inner medulla that normally occurs in
wild-type and homozygous RET51 and RET51(Y1062F)
animals. Developing glomeruli were identified in
RetRET51(Y1015F)/RET51(Y1015F) kidneys, although they were
scant and were scattered throughout the mesenchyme.
This suggests that the mesenchyme of these mice has
the ability to undergo differentiation to produce glo-
meruli; however, they are reduced in number presum-
ably due to UB branching deficits (Majumdar et al. 2003).
We next performed whole-mount dolichos biflorus ag-
glutinin (DBA) staining on the E15.5 GU system of
RetRET51(Y1015F)/RET51(Y1015F) mice to visualize the uri-
nary tree for abnormalities in branching morphogenesis
and the ureters (Sainio et al. 1997; Grisaru et al. 2001;
Figure 3. Mice expressing RET51(Y1015F)
exhibit severe ureter and kidney abnor-
malities. (A) Compared with wild-type
(WT), kidneys from 5-wk-old homozygous
RET51(Y1015F) mice exhibit megaureters
and renal atrophy. H&E sections at low
power demonstrate decreased renal paren-
chyma and dilated ureter (bar, 200 µm).
The micrograph at high power on the right
shows end-stage renal histology depicted
by globally sclerosed glomeruli (g), inflam-
mation (arrow), and multiple cystic tu-
bules (asterisks) with exudates and tubular
atrophy (bar, 100 µm). (B) Renal abnor-
malities in homozygous RET51(Y1015F)
mice are congenital. (Left) Morphology of
wild-type (WT) kidneys (K) depicting nor-
mal entry of ureters into the bladder (bl).
The gonads ([T] testis) and their ducts are
separated from the urinary tract and are
positioned near the bladder. The GU sys-
tem of homozygous RET51(Y1015F) mice
is composed of small kidneys, megaureter,
and testes attached to the kidney/ureter.
(Right) The H&E-stained sections show
hypodysplastic kidneys with multiple
cysts of varying sizes (first panel, scale bar,
50 µm), dilated ureter with a distal stric-
ture (arrowhead) that appeared to enter the
proximal urethra (double-headed arrow)
instead of the bladder (dashed circle) (second panel, scale bar, 800 µm), and testes aberrantly positioned next to the proximal ureter and
kidney (third panel, bar, 250 µm). (C) Comparison of the indicated RET mutants at P0 shows that kidneys of only the homozygous
RET51(Y1015F) mice are severely abnormal. The graph on the right shows a severe decrease in the number of glomeruli in kidneys of
RET51(Y1015F) mice compared with the other RET mutants (n = 6 kidneys, 3 animals of each genotype; mean ± SEM; [*] P < 0.05). Bar,
200 µm.
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Cheng et al. 2003). If these processes were normal in
RetRET51(Y1015F)/RET51(Y1015F) kidneys, one would expect
(1) a punctate DBA staining pattern in the kidneys due to
staining of branching UBs, (2) single ureters entering the
bladder, and (3) separation of gonads and wolffian duct
from the ureters as observed in wild-type and homozy-
gous RET51 and RET51(Y1062F) animals (Fig. 4B). In-
stead, DBA staining of the RetRET51(Y1015F)/RET51(Y1015F)
kidneys demonstrates bilateral supernumerary UBs that
are attached to the wolffian duct, a severe decrease in
branching morphogenesis, and failure of gonads to sepa-
rate from the kidneys/ureters (Fig. 4B,C; data not
shown). The presence of supernumerary UBs indicates
that multiple UB inductions have occurred in these mu-
tant mice. The decreased number of glomeruli is likely
due to the reduced UB branching. The inability of the
ureters to separate from the wolffian duct probably ac-
counts for the distal obstruction seen in the ureters of
postnatal mice as it likely poses an obstruction to urine
outflow. This would explain the histopathological fea-
tures of obstructive nephropathy observed in the postna-
tal kidneys of mutant mice.
Figure 4. Characterization of GU defects
mediated by RET51(Y1015F) during em-
bryogenesis. (A) H&E sections of E12.5
and E15.5 kidneys of indicated RET homo-
zygous mutants. A duplicated kidney (K1
and K2) is evident in homozygous
RET51(Y1015F) animals at E12.5. The lu-
men represents the initial branching of the
UB and indicates that the UB was able to
invade the metanephric mesenchyme. Also
note the mesenchymal condensation (mc),
indicating at least some degree of mesen-
chymal differentiation in RET51(Y1015F)
kidneys. At E15.5, the abnormal architec-
ture of mutant RET51(Y1015F) kidneys
was readily evident and included disorga-
nization with irregular distribution of pu-
tative glomeruli throughout the renal pa-
renchyma and duplicated kidneys (bar, 100
µm). In contrast, wild-type (WT) and the
other indicated RET mutant mice exhibit
a well-formed outer cortex and inner me-
dulla (separated by the dashed line) (bar,
200 µm). (B) Whole-mount DBA-FITC
staining of E15.5 kidneys. (Top) Normal
honeycomb pattern of UB branching,
single ureters entering the bladder (white
dot), and separation of wolffian duct (wd)
from the ureter was evident in kidneys (K)
of mice expressing wild-type, RET51, and
RET51(Y1062F). In RET51(Y1015F) ani-
mals, note bilateral small kidneys with su-
pernumerary UBs (arrows) that enter the
mesenchyme but show decreased branch-
ing and failed to separate from the wolffian
duct (wd) (white dashed line). The testes
(T) were also abnormally positioned. (Bot-
tom) Imaging of the above kidneys by con-
focal microscopy clearly depicts the dra-
matic deficit in branching morphogenesis
(arrowheads indicate branch points) in ho-
mozygous RET51(Y1015F) kidneys. Bar,
100 µm. (C) Quantitation of the branching
morphogenesis defect in E15.5 kidneys
from the indicated wild-type and RET mu-
tant mice (n = 3 animals of each genotype,
mean ± SEM; [*] P < 0.05). (D) Branching
defects in homozygous RET51(Y1015F)
mice are kidney-autonomous. Embryonic
kidneys (E12.5) were dissected from the wolffian duct (wd) and maintained in explant cultures. Visualization of the urinary tree in
kidneys from RET51(Y1015F) mice shows abnormal branching (top row, phase contrast; bottom row, DBA-FITC staining). Bar, 75 µm.
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Reduced branching morphogenesis is
kidney-autonomous in RetRET51(Y1015F)/RET51(Y1015F) mice
The developing murine kidney starts urine production
after E13.5 (Vize et al. 2003). Therefore, it is possible that
the decreased branching morphogenesis and the de-
creased number of glomeruli were due to obstruction and
not due to inherent defects in UB branching. To elimi-
nate this possibility, we cultured E12.5 wild-type and
RetRET51(Y1015F)/RET51(Y1015F) kidneys (dissected away
from the wolffian ducts) in vitro, and visualized UB
branching morphogenesis by DBA staining. In this set-
ting, the wild-type kidneys demonstrate normal UB
branching pattern, but the RetRET51(Y1015F)/RET51(Y1015F)
kidneys exhibit multiple ureters in the mesenchyme
with abortive attempts to branch (Fig. 4D). From the
above results, we conclude that RET51(Y1015) signaling
is necessary for ensuring outgrowth of a single UB and
promoting branching morphogenesis in the developing
kidney.
Decreased PLC activation and increased apoptosis
result in branching morphogenesis abnormalities
in RetRET51(Y1015F)/RET51(Y1015F) kidneys
Studies on biochemical characterization of oncogenic
RET signaling mutants in cell culture suggest that
RET(Y1015) and RET(Y1062) are key docking tyrosines
that activate PLC and AKT/MAPK signaling cascades,
respectively. We performed a series of experiments to
confirm that PLC and not AKT/MAPK is a target of
RET51(Y1015) in vivo, and to glean further insights into
the pathways and cellular processes that may explain the
RetRET51(Y1015F)/RET51(Y1015F) phenotype. First, biochemi-
cal analyses was performed on extracts from SCG neu-
rons of RetRET51(Y1015F)/RET51(Y1015F) mice. These neu-
rons were selected for biochemical analysis as they are
GDNF responsive and develop normally in these mice
(data not shown). Our results demonstrate that PLC
is not activated in homozygous RET51(Y1015F) mice,
whereas wild-type and RetRET51/RET51 mice show nor-
mal PLC activation (Fig. 5A). Second, there was no
difference between AKT and MAPK activation in
RetRET51(Y1015F)/RET51(Y1015F) and RetRET51/RET51 mice,
supporting the view that the RET51(Y1015F) phenotype
results from abrogation of PLC but not AKT/MAPK sig-
naling (Fig. 5B).
Third, as an alternative means to demonstrate that
PLC-mediated signaling regulates renal branching, we
treated E12.5 wild-type kidney explant cultures with a
PLC-specific inhibitor, Edelfosine (Horowitz et al. 2005).
We monitored renal branching with DBA staining and
found that Edelfosine treatment resulted in a dose-de-
pendent decrease in branching morphogenesis (Fig. 5C).
Fourth, in other systems Edelfosine-mediated reduction
in PLC signaling induces apoptosis (Cabaner et al. 1999;
Harguindey et al. 2000; Gajate and Mollinedo 2002). This
fact raised the possibility that decreased renal branching
and nephrogenesis in homozygous RET51(Y1015F) mice
could be a result of increased apoptosis due to abroga-
tion of PLC signaling in these mice. Indeed, when
compared with wild-type and RetRET51/RET51 kidneys,
RetRET51(Y1015F)/RET51(Y1015F) kidneys show a dramatic
increase in apoptosis as assessed by TUNEL staining
(Fig. 5D). These results, when taken together along with
kidney defects observed in PLC1-null chimeras, provide
compelling evidence that abrogation of RET51(Y1015)-
mediated PLC1 signaling and resultant apoptosis are
responsible for defective branching morphogenesis in the
Figure 5. Kidney deficits in RET51(Y1015F) mice result from
abnormalities in PLC signaling and increased apoptosis. (A)
Western blots of primary SCG neuron lysates immunoblotted
(IB) with phospho PLC (pPLC) show absence of GDNF-stimu-
lated pPLC in homozygous RET51(Y1015F) compared with
control lysates (homozygous RET51 and wild-type animals).
Note that the antibody cross-reacts with phosphorylated RET
that serves as an internal control, indicating no overt effect on
total RET phosphorylation (see Materials and Methods). (B)
Similar experiment as above with pAKT and pERK antibodies
shows that the activation of AKT and MAPK is normal in
RET51(Y1015F) animals. (C) PLC inhibition in wild-type kid-
neys recapitulates decreased renal branching phenotype. A PI-
PLC inhibitor, Edelfosine, shows a dose-dependent decrease in
UB branching relative to control (vehicle-treated) E12.5 wild-
type (WT) kidney explants (visualized with DBA-FITC; n > 5).
(D) The kidneys of homozygous RET51(Y1015F) mice show in-
creased apoptosis as depicted by TUNEL staining (red nuclei),
compared with wild-type and homozygous RET51 E15.5 kid-
neys (n  3 animals). Bar, 50 µm.
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RetRET51(Y1015F)/RET51(Y1015F) kidneys (Shirane et al.
2001), and suggest that patients with CAKUT may also
have PLC signaling abnormalities.
Roles of RET docking tyrosines in the context
of RET9 isoform
The above studies elucidated the physiologic roles of sig-
naling pathways emanating from the major phosphoty-
rosine residues in the context of the RET51 isoform. To
determine whether abrogation of signals from these resi-
dues in the RET9 isoform also resulted in physiologic
deficits, we characterized renal development in mice
with mutations in these docking tyrosines in the RET9
isoform (Y981, Y1015, and Y1062). Morphological analy-
sis revealed partially penetrant unilateral megaureter in
RetRET9(Y981F)/RET9(Y981F) mice (4/14), and bilateral mega-
ureter, multicystic, and hypodysplastic kidneys in all
RetRET9(Y1015F)/RET9(Y1015F) mice (n > 15) (Fig. 6A,B). Kid-
neys of RetRET9(Y1015F)/RET9(Y1015F) mice displayed fea-
tures similar to those of RetRET51(Y1015F)/RET51(Y1015F)
mice including supernumerary UBs, hypodysplastic kid-
neys, and failure of gonads to separate from wolffian
ducts (Fig. 6A–C). This suggests that in kidney develop-
ment, signals emanating from Y1015 in both RET9 and
RET51 are equivalent.
More interestingly, in contrast to apparently normal
kidneys of homozygous RET51(Y1062F) mice, the kid-
neys of all RetRET9(Y1062F)/RET9(Y1062F) mice were abnor-
mal (100% penetrance) and displayed variable expressiv-
ity including bilateral agenesis, unilateral agenesis, and
kidney rudiments (Fig. 6A–C). The histological abnor-
malities observed in the rudiments are similar to Ret-
null mice and include markedly reduced numbers of glo-
meruli, dysplasia, multiple cysts, and absence of neph-
rogenic zone (n > 5). The ureters and gonads were
normal. Thus, compared with kidneys of homozygous
RET51(Y1062F) mice, kidney development was severely
affected in homozygous RET9(Y0162F) mice. It should
be noted that numerous studies have shown that the
Y1062F mutation does not affect RET stability or overall
phosphorylation; thus the deficits in RET9(Y0162F) mice
are likely to result from aberrant RET signaling through
this critical docking tyrosine (Asai et al. 1996; Segouffin-
Cariou and Billaud 2000; Jain et al. 2004; Jijiwa et al.
2004). The similarity of the kidney phenotype of these
mice to Ret nulls suggests that signaling cascades acti-
vated by Y1062 are critical for initiating UB outgrowth.
RET(Y1062) is a critical tyrosine for activation of AKT
and MAPK signaling cascades, yet in our studies we saw
a major kidney defect only when the Y1062F mutation
was present in RET9 (Besset et al. 2000; Hayashi et al.
2000). One reason that activation of AKT and MAPK is
relatively normal in RetRET51(Y1062F)/RET51(Y1062F) kid-
neys is because these signaling pathways in RET51 can
also be activated by RET(Y1096), which is not present in
RET9 (Besset et al. 2000). Consistent with this reason-
ing, comparison of AKT and MAPK activation in
RetRET9(Y1062F)/RET9(Y1062F), RetRET51(Y1062F)/RET51(Y1062F)
mice with the wild-type RetRET9/RET9 and RetRET51/RET51
mice, respectively, shows a marked decrease in AKT and
MAPK phosphorylation in RetRET9(Y1062F)/RET9(Y1062F)
but not in RetRET51(Y1062F)/RET51(Y1062F) mice (Fig. 6D).
To further support the idea that the C terminus of RET51
provides redundancy in kidney development, we gener-
ated hybrid-isoform mice RetRET9(Y1062F)/RET51(Y1062F),
which harbor the Y1062F mutation in each of the RET9
and RET51 alleles. These mice did not have any major
renal anomalies (n = 3) (Fig. 6B). Normal activation of
AKT and MAPK in homozygous RET51(Y1062F) animals
due to redundancy may explain the normal kidney de-
velopment in homozygous RET51(Y1062F) mice.
Discussion
Loss-of-function studies have demonstrated essential
roles of several proteins in kidney development and con-
genital renal disease including GDNF, GFR1, RET,
Wnt11, SPRY1, SLIT2/ROBO2, WT1, and PAX2 (Yu et
al. 2004). However, what components or signaling path-
ways lead to the abnormal phenotypes is unclear. To
identify the signaling pathways mediated by RET that
are important in GU development, we generated several
“humanized” mutant RET mice that disrupt key RET-
dependent signal transduction pathways. The results
provide several novel insights into RET biology, RTK
signaling specificity, kidney development, and molecu-
lar pathogenesis of CAKUT and provide animal models
of congenital renal diseases.
First, we discovered that signaling by either RET9 or
RET51 is sufficient for kidney formation, that is, the
wild-type human RET isoforms have redundant roles in
GU development, and the human RET forms can func-
tion in mice. This result was surprising since a previous
study on chimeric mouse–human Ret monoisomorphic
mice found that the chimeric Ret51 did not support nor-
mal kidney development and resulted in perinatal lethal-
ity (de Graaff et al. 2001). Using RNA analysis, we ex-
cluded the possibility that our RET51 homozygous mice
expressed any endogenous mouse Ret or Ret9 mRNA
that could account for our different results. The levels
of RET and ligand-dependent activation of AKT and
MAPK, a critical pathway for RET activity, were also
similar in our RET monoisomorphic mice. Importantly,
four other RET51 knockin mice with different muta-
tions [RET51(Y981F), RET51(Y1062F), RET51(Cdel), and
RET9(51C)] also had essentially normal kidney develop-
ment, indicating that the human RET51 can clearly sus-
tain kidney development in mice. Differences between
our work and the study of de Graaff et al. (2001) may be
attributed to factors such as environmental or genetic
strain differences or the different properties of human
RET51 (used in our study) and chimeric murine Ret51
(used in the de Graaff study). Support for this latter idea
consistent with our findings comes from the observation
that wild-type human RET51 and RET9 promote branch-
ing morphogenesis to a similar extent, but the Y1062F
mutation abrogates this activity only in RET9 and not in
RET51, presumably because of redundancy through
Y1096 (see below) (Degl’Innocenti et al. 2004). In con-
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trast, murine Ret9, and not Ret51, promotes tubulogen-
esis (Schuetz et al. 2004).
The only urinary phenotype we observed in wild-type
monoisoformic mice is partial penetrance for unilateral
dilated ureters in a small number of homozygous RET9
(3/50) and RET51 (1/50) mice. Some studies have sug-
gested that human RET is less active than mouse Ret
due to differences in their ability to interact with the
Figure 6. GU development in mice expressing docking tyrosine mutations in the RET9 isoform. (A) Gross depiction of spectrum of
renal anomalies at the indicated ages in mice expressing RET9(Y981F), RET9(Y1015F), and RET9(Y1062F). In RET9(Y981F), partial
penetrance of unilateral dilated ureter (dashed line, 4/12 animals) is shown. Examples of the progression of renal abnormalities in mice
expressing RET9(Y1015F) show dilated ureters and abnormally positioned gonads at P0. By postnatal day 7 (P7), megaureters and
compression of the kidneys were evident. By P35, normal kidney tissue was absent, and the testes and the vas deferens were attached
to the proximal portion of the dilated ureter. In mice expressing RET9(Y1062F), renal agenesis (unilateral and bilateral) or kidney
rudiments (cf. the size of the kidney with adrenal glands) were observed. The ureters and gonads of these animals were grossly normal.
(B) Renal dysplasia in mice expressing RET9(Y1015F) or RET9(Y1062F). H&E-stained sections of the indicated kidneys at P0 depict the
dysplastic appearance in kidneys of homozygous RET9(Y1015F) and RET9(Y1062F)mice. Note that the presence of RET51(Y1062F) in
the heteroisomorphic RET(Y1062F) kidneys (RetRET9(Y1062F)/RET51(Y1062F)) resulted in histologically normal kidneys, indicating the
importance of redundant signaling emanating from the RET51 C terminus in kidney development. (C) Whole-mount DBA-FITC
staining of E15.5 homozygous RET9(Y1015F) and RET9(Y1062F) kidneys reveals that the defects in mice expressing RET9(Y1015F)
(supernumerary UBs, decreased branching, abnormal gonads) were similar to kidney defects in mice expressing RET51(Y1015F). At
E15.5, renal agenesis or rudiments were evident in mice expressing RET9(Y1062F) as opposed to normal development of kidneys of
mice expressing RET51(Y1062F) (see Fig. 4). (D) Comparison of AKT and MAPK activation in homozygous RET9(Y1062F) and
RET51(Y1062F) mice. Western blots of SCG lysates (as in Fig. 5) from mice expressing the indicated RET mutations show that AKT
and MAPK activation is severely decreased in mice expressing RET9(Y1062F) compared with those expressing RET9, RET51, or
RET51(Y1062F). Bars, A, 2 mm; B, 200 µm.
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GFLs and may explain the unilateral, partially penetrant
GU defects in humanized monoisomorphic RET mice
(Skinner et al. 2005). Because unilateral GU abnormali-
ties are one of the commonest presentations of CAKUT,
we suggest that some of this incidence may be due to
decreased RET activity, as differences in RET signaling
can result in incomplete penetrance and variable expres-
sivity (Moore et al. 1996; Pichel et al. 1996; Sanchez et al.
1996; McCallion et al. 2003; Jain et al. 2004; Jijiwa et al.
2004).
Second, we discovered that the docking tyrosines of
both RET9 and RET51 have distinct as well as redundant
physiological roles in kidney development. Our bio-
chemical, embryological, genetic, and pharmacological
analyses of the GU system of homozygous RET(Y1015F)
mice clearly establish the importance of RET(Y1015)-
mediated PLC1 activation in ensuring proper out-
growth of a single UB and branching morphogenesis.
Disruption of PLC1 signaling results in supernumerary
UBs, branching morphogenesis defects, hypodysplastic
kidneys, failure of gonads to separate from the urinary
tract, and multiple cysts ultimately leading to end-stage
kidneys by 1 mo after birth. In these mice, the UBs are
capable of invading the metanephric mesenchyme and
initiating early branching, indicating that RET(Y1015)
signaling is not required for these events. Rather, the
UB outgrowth and early branching are regulated by
RET9(Y1062) since homozygous RET9(Y1062F) mice ei-
ther do not develop kidneys or have only kidney rudi-
ments, similar to Ret-null animals (see below). While the
role of PLC1 in renal development was previously sug-
gested from analysis of high percentage chimeras gener-
ated from plc1−/− ES cells (Plc1-null mice are embry-
onically lethal), our results now provide evidence that
this requirement is largely, if not entirely, mediated by
RET(Y1015) (Shirane et al. 2001).
The fact that Y1015F kidneys do exhibit some branch-
ing, albeit decreased, suggests that other signaling path-
ways may also contribute to this event after initial UB
induction. We could not evaluate this possibility in our
monoisomorphic RET9(Y1062F) mice (because of renal
agenesis), or in RET51(Y1062) mice since they had nor-
mal renal branching. However, diminished, but not ab-
sent, renal branching is observed in mice where signaling
through endogenous mouse Ret(Y1062) is disrupted (Ji-
jiwa et al. 2004). Together, these studies support the idea
that normal branching requires intact signaling by both
Y1015 and Y1062. Since proper branching morphogen-
esis prevents apoptosis of the mesenchyme and ensures
normal nephron differentiation, defects in branching
morphogenesis explain the increased apoptosis, hypo-
dysplastic kidneys, and decreased glomeruli in
RET(Y1015F) kidneys. Thus, different signaling path-
ways activated by RET (PLC1 vs. AKT/MAPK) have
distinct as well as redundant functions in kidney devel-
opment. Whether Y981 has a role in kidney develop-
ment is uncertain because of the partial penetrance of
unilateral ureter defects in homozygous RET9 and
RET9(Y981F). Our initial analysis revealed that the in-
cidence of these partially penetrant GU defects is higher
in homozygous RET9(Y981F) animals (4/12) compared
with wild-type RET9 animals (3/50), suggesting that
Y981 may only have a modest role, if any, in kidney
development (p = 0.03, Fisher’s exact test).
A third important insight from our studies is that the
mechanism of Sprouty1 regulation by Ret may be via
RET(Y1015)-mediated PLC1 activation (Basson et al.
2005). The GU phenotype of homozygous RET(Y1015F)
is remarkably similar to Sprouty1-null mice (e.g., super-
numerary UBs, failure of vas deferens to separate from
the ureters, hypodysplastic kidneys, gonads attached to
the GU system) and to other mouse models in which
aberrant Sprouty expression affects UB branching and
outgrowth by modulating Wnt11–GDNF–Ret signaling
(Majumdar et al. 2003; Chi et al. 2004; Basson et al.
2005). These studies demonstrate that absence of Ret sig-
naling results in loss of Sprouty1 expression in wolffian
ducts, which, in turn, renders these ducts more sensitive
to GDNF and results in induction of supernumerary
UBs. The phenotypic similarity between homozygous
RET(Y1015F)- and Sprouty1-null mice, along with obser-
vations demonstrating that RET(Y1015) is the major
docking tyrosine for PLC1 activation and that Sprouty
expression is regulated by PLC (Abe and Naski 2004),
strongly suggest that Sprouty signaling may be modu-
lated by RET(Y1015)-mediated PLC activation.
Sprouty1 proteins are repressors of RTK signaling and
interact with various adaptor proteins (Kim and Bar-Sagi
2004). It is possible that RET51(Y1015F) mutation re-
sults in decreased Sprouty expression in wolffian ducts,
or causes aberrant signaling through GRB2–SOS com-
plexes due to failure of Sprouty phosphorylation. In
addition, it was recently reported that deficient SLIT2
(expressed by UB tips)-mediated ROBO2 (expressed by
mesenchyme) signaling results in supernumerary UBs
and ureter remodeling abnormalities similar to those
present in RET(Y1015F) mice and other mutant mice
with aberrant GDNF/Ret signaling (Sainio et al. 1997;
Batourina et al. 2002; Grieshammer et al. 2004). Whether
Sprouty1 or SLIT2-ROBO2 is a component of the path-
way regulated by RET(Y1015) will require further study.
The fourth important finding of our studies is the in
vivo evidence that the C terminus of RET51, which har-
bors an additional docking site (Y1096) not present in
RET9, provides redundancy in kidney development
through activation of AKT/MAPK pathways. The resi-
due Y1062 is present in both RET9 and RET51 and in-
teracts with PTB/SH2 domain-containing adaptor pro-
teins including Shc, Doks 1–6, and FRS1 to activate
PI3K–AKT and ERK–MAPK pathways. Because we gen-
erated monoisoformic mice with impairment of signal-
ing through Y1062, we were able to compare the role of
this residue in the context of both isoforms. Our results
demonstrate that kidneys do not develop or are rudimen-
tary in RET9(Y1062F) animals. This phenotype is similar
to that of Ret-null mice and to the recent report by Wong
et al. (2005) that Ret9-Y1062F signaling is critical for UB
outgrowth and enteric nervous system development.
The markedly diminished to absent AKT/MAPK activa-
tion in these mice also shows that this pathway is im-
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portant for UB outgrowth (Schuchardt et al. 1996; Fisher
et al. 2001; Tang et al. 2002). Such severe abnormalities
are not present in RET51(Y1062F) mice because AKT/
MAPK activation is relatively intact in these mice, pre-
sumably due to redundancy from Y1096-Grb2 signaling
as reported in other studies (Lorenzo et al. 1997; Besset et
al. 2000; Degl’Innocenti et al. 2004).
An important observation from this study and others
is that variable expressivity of renal abnormalities due to
defects in UB outgrowth correlates with differences in
RET-mediated AKT/MAPK activation (Jain et al. 2004;
Jijiwa et al. 2004). For example, complete loss of signal-
ing through RET(Y1062) as seen in RET9(Y1062F) or Ret-
null mice results in renal agenesis, while diminished
RET-mediated AKT/MAPK activity, as occurs in RetDN
mice, results in less severe renal abnormalities that in-
clude hypoplasia and incomplete penetrance of renal
agenesis (Jain et al. 2004). Similarly, a mutation at Y1062
in the endogenous mouse Ret locus results in renal hy-
poplasia but not renal agenesis, presumably because
Ret9 is more abundant than Ret51 in murine embryonic
kidneys (Lee et al. 2003; Jijiwa et al. 2004). Finally,
double heterozygotes containing a single allele of each of
knocked-in human RET9(Y1062F) and RET51(Y1062F)
have normal kidneys, again demonstrating the redun-
dant signaling occurring via the RET51(Y1096) residue.
All these studies taken together suggest that a wide spec-
trum of congenital anomalies due to UB outgrowth in
humans can be due to alterations in the levels of the
RET-dependent AKT/MAPK pathway.
Distinct biological activities of individual isoforms of
a number of other RTKs (e.g., Met, PDGFR, insulin re-
ceptor, FGFR1) have been observed (Orian-Rousseau et
al. 2002; Pandini et al. 2002). Our results in vivo present
for the first time that key signaling pathways dependent
on RET also have distinct and redundant roles in kidney
development. Renal tract malformations account for
30% of anomalies diagnosed prenatally, and renal mal-
formations are a major cause of chronic renal failure in
children (Noia et al. 1989; Woolf and Thiruchelvam
2001). Our results from genetic experiments in mice phe-
nocopy several of these anomalies and provide poten-
tially important paradigms for understanding the mo-
lecular basis for these diseases.
Materials and methods
Generation of various Ret knockin mice
Institution-approved protocols were followed for all animal
studies. Human RET9, RET51, and the indicated mutant
cDNAs were homologously recombined into the first coding
exon of the Ret gene to disrupt synthesis of the endogenous
mouse Ret as previously described (Fig. 1A,B; Enomoto et al.
2001; see Supplemental Material for details).
Tissue RNA analysis
Total RNA was isolated from brain and analyzed by RT–PCR as
previously described (Svaren et al. 2000). Total Ret transcripts
(representing endogenous mouse and the inserted human se-
quences) were identified as before (Jain et al. 2004). Primers to
detect mouse Ret and total (mouse and human) Ret51 or Ret9
are described in the Supplemental Material.
Histopathological analysis and immunohistochemistry
Mouse tissues were fixed in 4% paraformaldehyde and pro-
cessed as previously described (Enomoto et al. 2000). Routine
histological assessment was done on hematoxylin and eosin-
stained (H&E) tissue sections. Cell death was analyzed using
TUNEL assay (Boehringer Mannheim) (Enomoto et al. 2000).
Immunohistochemistry with anti-RET antibody (Neuromics; 1:
100, goat polyclonal) and visualization of the urinary tree with
DBA is described in the Supplemental Material.
Western blot analysis
Western blots of cell extracts from primary SCG cultures were
performed as described previously, and the details of the anti-
bodies used are provided in the Supplemental Material (Tsui-
Pierchala et al. 2002; Encinas et al. 2004).
Embryonic kidney organ cultures and treatments
Developing kidneys from E12.5 wild-type or RET mutant em-
bryos were dissected away from wolffian duct and cultured at
air–fluid interface as previously described (Supplemental Mate-
rial; Rogers et al. 1991; Cheng et al. 2003). The organ cultures
were maintained for 72 h and then fixed for 10 min, washed in
PBS, and stained with FITC-DBA for analysis. Conditions for
treatment with the PLC inhibitor Edelfosine (Calbiochem) are
described in the Supplemental Material.
Microscopic analyses and quantitation
Images for brightfield and immunofluorescence on tissue sec-
tions (Nikon Eclipse 80i), gross morphology (Nikon), and DBA-
FITC whole-mount specimens (Leica) were captured (Cool-
SnapES camera for fluorescence and CoolSnapCF for color im-
ages) and processed using Metamorph and Adobe Photoshop CS
software. Visualization of the E15.5 kidneys at high resolution
and quantitation of branching were done by confocal micros-
copy as detailed in the Supplemental Material. Glomerular
counts were obtained from P0 kidneys that were sectioned in
entirety as previously described (Jain et al. 2004). Quantitative
analyses were performed with SigmaPlot software (SPSS Inc.),
and statistical significance was determined with the Student
t-test unless otherwise specified. For all studies, the sample size
was three or more for each genotype.
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